Cargando…
Exploring Cardio-Metabolic Effects of Liraglutide in Patients With Type 2 Diabetes Through a Proteomic Approach
Background: Diabetes is associated with complications that increase the risk of cardiovascular events in diabetic patients by 3 folds compared to healthy population. Liraglutide is a GLP-1 receptors agonist that showed cardiovascular benefits beside its glycemic advantage and weight reduction. The c...
Autores principales: | Ekhzaimy, Aishah Ali, Masood, Afshan, Benabdelkamel, Hicham, Elhassan, Tasnem, Alfadda, Assim A |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8265938/ http://dx.doi.org/10.1210/jendso/bvab048.582 |
Ejemplares similares
-
Plasma proteomics reveals an improved cardio-metabolic profile in patients with type 2 diabetes post-liraglutide treatment
por: Ekhzaimy, Aishah A, et al.
Publicado: (2022) -
Urinary Proteome Differences in Patients with Type 2 Diabetes Pre and Post Liraglutide Treatment
por: Rafiullah, Mohamed, et al.
Publicado: (2023) -
Plasma-Based Proteomics Profiling of Patients with Hyperthyroidism after Antithyroid Treatment
por: Masood, Afshan, et al.
Publicado: (2020) -
Proteomics Profiling of the Urine of Patients with Hyperthyroidism after Anti-Thyroid Treatment
por: Benabdelkamel, Hicham, et al.
Publicado: (2021) -
Identification of Protein Changes in the Urine of
Hypothyroid Patients Treated with Thyroxine Using Proteomics Approach
por: Masood, Afshan, et al.
Publicado: (2021)